April 18, 2017 Acad, Gov/Utilities Bio/Pharma/CRO

FDA grants Roche’s TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer

Basel, 18 April 2017 FDA grants Roche’s TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer First and only cancer immunotherapy approved in advanced bladder cancer as initial treatment for those unable to receive cisplatin chemotherapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug... Read more

April 18, 2017 Cell Analysis Tools M&A, Partnerships

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies

April 18, 2017 06:00 AM Pacific Daylight Time MADISON, Wis.–(BUSINESS WIRE)–Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cell-derived products, today announced it has signed a distribution agreement with STEMCELL Technologies, a world leader in iPS cell culture media. “This joint agreement with STEMCELL Technologies will... Read more